NYSEAMERICAN:CRHMCRH Medical Stock Price, Forecast & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRH Medical in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for CRH Medical.

CRH Medical is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for CRH Medical.

CRH Medical Corp (NYSEAMERICAN:CRHM) posted its quarterly earnings results on Tuesday, May, 12th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.01 by $0.04. The firm had revenue of $25.46 million for the quarter, compared to analyst estimates of $28.70 million. View CRH Medical's earnings history.

4 brokers have issued 12-month price targets for CRH Medical's stock. Their forecasts range from $3.50 to $4.00. On average, they anticipate CRH Medical's stock price to reach $3.75 in the next twelve months. This suggests a possible upside of 62.3% from the stock's current price. View analysts' price targets for CRH Medical.

News coverage about CRHM stock has been trending negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CRH Medical earned a news impact score of -2.1 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about CRH Medical.

CRH Medical saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 36,000 shares, an increase of 78.2% from the June 15th total of 20,200 shares. Based on an average daily volume of 150,200 shares, the short-interest ratio is currently 0.2 days. Approximately 0.1% of the company's stock are sold short. View CRH Medical's Current Options Chain.

Some companies that are related to CRH Medical include Advanced Medical Solutions Group (AMS), Clover (CLV), InfuSystem (INFU), Bovie Medical (BVX), CRH Medical (CRH), Tristel (TSTL), Retractable Technologies (RVP), SDI (SDI), Milestone Scientific (MLSS), Omega Diagnostics Group (ODX), Daxor (DXR), Daxor (DXR), IsoRay (ISR), IsoRay (ISR) and TSO3 (TOS). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other CRH Medical investors own include CRH Medical (CRH), AcelRx Pharmaceuticals (ACRX), Extreme Networks (EXTR), Alimentation Couche-Tard (ATD.B), Dollarama (DOL), NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Pieris Pharmaceuticals (PIRS), Palatin Technologies (PTN) and Ring Energy (REI).

CRH Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CRHM."

Shares of CRHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CRHM stock can currently be purchased for approximately $2.31.

CRH Medical has a market capitalization of $165.35 million. CRH Medical employs 112 workers across the globe.

The official website for CRH Medical is investors.crhsystem.com.

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.